Prelude Therapeutics
We are a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers affecting patients with high unmet need, where there are limited or no treatment options. Since our inception in 2016, we have received clearance from the U.S. Food and Drug Administration, or the […]
September 6, 2020 Read More